trending Market Intelligence /marketintelligence/en/news-insights/trending/h0Oful0bTy473uwzUMEXGQ2 content esgSubNav
In This List

Eli Lilly exec joins Ardelyx board

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Eli Lilly exec joins Ardelyx board

Ardelyx Inc. said March 14 that it appointed Jan Lundberg to its board, effective March 23.

Lundberg is executive vice president of science and technology and president of Lilly Research Laboratories at Eli Lilly and Co.

Fremont, Calif.-based Ardelyx develops and sells therapeutics for the treatment of cardiorenal and gastrointestinal diseases in the U.S.